- Home
- ERNA vs IMCC Comparison
ERNA vs IMCC Comparison
Compare ERNA & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERNA
- IMCC
- Stock Information
- Founded
- ERNA 2018
- IMCC 1980
- Country
- ERNA United States
- IMCC Israel
- Employees
- ERNA N/A
- IMCC N/A
- Industry
- ERNA Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- ERNA Health Care
- IMCC Health Care
- Exchange
- ERNA Nasdaq
- IMCC Nasdaq
- Market Cap
- ERNA 13.5M
- IMCC 11.8M
- IPO Year
- ERNA N/A
- IMCC N/A
- Fundamental
- Price
- ERNA $1.92
- IMCC $2.85
- Analyst Decision
- ERNA
- IMCC
- Analyst Count
- ERNA 0
- IMCC 0
- Target Price
- ERNA N/A
- IMCC N/A
- AVG Volume (30 Days)
- ERNA 53.7K
- IMCC 74.4K
- Earning Date
- ERNA 08-12-2025
- IMCC 08-13-2025
- Dividend Yield
- ERNA N/A
- IMCC N/A
- EPS Growth
- ERNA N/A
- IMCC N/A
- EPS
- ERNA N/A
- IMCC N/A
- Revenue
- ERNA $535,000.00
- IMCC $37,894,737.00
- Revenue This Year
- ERNA N/A
- IMCC $47.12
- Revenue Next Year
- ERNA N/A
- IMCC $12.83
- P/E Ratio
- ERNA N/A
- IMCC N/A
- Revenue Growth
- ERNA 365.22
- IMCC 12.68
- 52 Week Low
- ERNA $1.75
- IMCC $1.29
- 52 Week High
- ERNA $32.40
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- ERNA 39.97
- IMCC 48.66
- Support Level
- ERNA $1.91
- IMCC $2.90
- Resistance Level
- ERNA $2.57
- IMCC $3.21
- Average True Range (ATR)
- ERNA 0.18
- IMCC 0.34
- MACD
- ERNA 0.04
- IMCC -0.06
- Stochastic Oscillator
- ERNA 19.77
- IMCC 16.16
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.